COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,900 Articles (22,568 medRxiv, 8,332 bioRxiv)

Most recent first Previous |  Page 452: Articles 4511-4520  | Next

Optimal Delivery Management for the Prevention of Early Neonatal SARS-CoV-2 Infection: Systematic review and Meta-analysis
Chan, C. S., Kong, J. Y., Sultana, R., Mundra, V., Babata, K., Mazzarella, K., Adhikari, E., Yeo, K. T., Hascoet, J.-M., Brion, L. P.
10.1101/2023.02.14.23285921 — Posted: 2023-02-15
Low Antibody Titers Demonstrate Significantly Increased Rate of SARS-CoV-2 Infection in a Highly Vaccinated Population from the National Basketball Association
Tai, C., Haviland, M. J., Kissler, S. M., Lucia, R. M., Merson, M., Maragakis, L. L., Ho, D. D., Anderson, D. J., DiFiori, J., Grubaugh, N. D., Grad, Y. H., Mack, C. D.
10.1101/2023.02.10.23285780 — Posted: 2023-02-14
Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older: analysis of nation-wide patient electronic health records in the United States
Gorenflo, M., Davis, p. B., Kaelber, D., Xu, R.
10.1101/2023.02.11.23285801 — Posted: 2023-02-14
Sustained systemic hyaluronan in COVID-19 patients, a 3D-lung model reveals mechanisms of overproduction counteracted by cortisone
Hellman, U., Rosendal, E., Edin, A., Henriksson, J., Forsell, M., Lange, A., Ahlm, C., Blomberg, A., Cajander, S., Normark, J., Överby, A. K., Lenman, A.
10.1101/2023.02.10.23285332 — Posted: 2023-02-14
Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY
Pearce, F. A., Lim, S. H., Bythell, M., Lanyon, P., Hog, R., Taylor, A., Powter, G., Cooke, G., Ward, H., Chilcot, J., Thomas, H., Mumford, L., McAdoo, S. P., Pettigrew, G. J., Lightstone, L., Willicombe, M.
10.1101/2023.02.09.23285649 — Posted: 2023-02-14
Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide analysis of programme data and health system vulnerabilities
Surendra, H., Elyazar, I., Puspaningrum, E., Darmawan, D., Pakasi, T., Lukitosari, E., Sulistyo, S., Deviernur, S., Fuady, A., Thwaites, G., van Crevel, R., Shankar, A., Baird, J. K., Hamers, R.
10.1101/2023.02.09.23285740 — Posted: 2023-02-14
Quantifying the rate and magnitude of the Omicron outbreak in China after sudden exit from 'zero-COVID' restrictions
Goldberg, E. E., Lin, Q., Romero-Severson, E. O., Ke, R.
10.1101/2023.02.10.23285776 — Posted: 2023-02-14
The long COVID evidence gap: comparing self-reporting and clinical coding of long COVID using longitudinal study data linked to healthcare records.
Knuppel, A., Boyd, A., Macleod, J., Chaturvedi, N., Williams, D. M.
10.1101/2023.02.10.23285717 — Posted: 2023-02-14
Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study
Ghani, A. C.
10.1101/2023.02.09.23285743 — Posted: 2023-02-14
Sarbecoviruses of British Horseshoe Bats; Sequence Variation and Epidemiology
Apaa, T., Withers, A. J., Staley, C. E., Blanchard, A. M., Bennett, M., Bremner-Harrison, S., Chadwick, E. A., Hailer, F., Harrison, S. W. R., Loose, M., Mathews, F., Tarlinton, R. E.
10.1101/2023.02.14.528476 — Posted: 2023-02-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).